Pathological α-Synuclein Perturbs Nuclear Integrity
Michael MillettiD, Allison Comite, Elisabeth Martin CastosaiD, Anika J. HeubergeriD, Preston Wagner, Ignacio Gallardo, Jessica Reinhardt, Nicole ChambersiD, Dominic HalliD, Evan Miller, Douglas Nabert, Barbara Balsamo, Stefan ProkopiD, Mark S. MoehleiD
Abstract
Pathological aggregates of -synuclein are a hallmark of a group of neurodegenerative disorders collectively termed synucleinopathies. The physiological function of -synuclein, and the detrimental effects of the pathological variants of -synuclein have been widely debated, but recent evidence has suggested an emerging consensus on a critical role for -synuclein in regulating synaptic function. However, a controversial role for -synuclein in nuclear function in both normal and pathogenic states has been proposed, and the degree to which -synuclein localizes within the nucleus and subsequent impact on the nucleus are poorly understood. To begin to address this controversy, we employed synucleinopathy murine and cell culture models, as well as postmortem human Lewy Body Dementia tissue to elucidate the extent to which pathological -synuclein localizes within the nuclear compartments, and the downstream consequences of this localization. We observed pathological aggregation of -synuclein within the nucleus in both murine models and human postmortem Lewy Body Dementia cortex via quantitative super resolution microscopy. In both mouse and human brain tissue the presence of -synuclein in the nucleus correlated with abnormal morphology of nuclei. This pathological accumulation of -synuclein in the nucleus was not observed in control mice, human tissue without pathology, or control cells. We subsequently examined the mechanistic consequences of pathological accumulation of -synuclein in the nucleus. Synucleinopathy models displayed increased levels of the DNA damage marker 53BP1. Furthermore, cells with pathological -synuclein exhibited elevated markers of nuclear envelope damage and abnormal expression of nuclear envelope repair markers. Our cell culture data also suggests altered RNA localization in response to pathological -synuclein accumulation within the nucleus. Lastly, we show that nuclear Lewy-like pathology leads to increased sensitivity to nuclear targeted toxins. Taken together, these results rigorously illustrate nuclear localization of pathological -synuclein with super resolution methodology and provide novel insight into the ensuing impact on nuclear integrity and function.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 4.87
- Field percentile
- top 4%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
D. J. Koss, D. Erskine, … T. F. Outeiro·bioRxiv·Oct 20, 2021
- Post-mortem evidence for a reciprocal relationship between genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies.
David J. Koss, Olivia Todd, … Tiago F. Outeiro·bioRxiv·Apr 24, 2024
- Presynaptic accumulation of α-synuclein causes synaptopathy and progressive neurodegeneration
Jéssika Cristina Bridi, Erika Bereczki, … Frank Hirth·Brain CommunicationsPeer-reviewed·Mar 19, 2021
- Aquaporin-4 mis-localization slows glymphatic clearance of α-synuclein and promotes α-synuclein pathology and aggregate propagation
Molly Braun, Matthew J. Simon, … Jeffrey J. Iliff·bioRxiv·Aug 14, 2024
- Cortical synaptic vulnerabilities revealed in a α-synuclein aggregation model of Parkinson's disease
Saroj Kumar Sah, Andrew D. Sauerbeck, … Thomas Biederer·bioRxiv·Jun 20, 2024
- Pathological α-synuclein elicits granulovacuolar degeneration independent of tau
Dylan J. Dues, Madalynn L. Erb, … Darren J. Moore·Translational NeurodegenerationPeer-reviewed·Jun 19, 2025